Dise Disease Man anag agement to t to Prom omote te Blood - - PowerPoint PPT Presentation

dise disease man anag agement to t to prom omote te blood
SMART_READER_LITE
LIVE PREVIEW

Dise Disease Man anag agement to t to Prom omote te Blood - - PowerPoint PPT Presentation

Dise Disease Man anag agement to t to Prom omote te Blood Blood Pressu sure C Con ontr trol ol A Amon mong African an A Ame mericans Fishbow s Fishbowl l Ren A. Vega Aetna Scaling and Spreading Innovation Strategies to


slide-1
SLIDE 1

Dise Disease Man anag agement to t to Prom

  • mote

te Blood Blood Pressu sure C Con

  • ntr

trol

  • l A

Amon mong African an A Ame mericans Fishbow s Fishbowl l

René A. Vega Aetna

Scaling and Spreading Innovation Strategies to Improve Cardiovascular Health April 19, 2012

slide-2
SLIDE 2

Af Afri rican Am Ameri rican an Hy Hyper perten ension – The Fa Facts cts

1Archives of Internal Medicine, 1997 2AHA 2001 Heart and Stroke Statistical Update 3 JNC VII 2004 4 Circulation 2009

Compared to Whites, African Americans have a higher prevalence of hypertension1,2 African Americans also have higher rates of cardiovascular mortality, stroke, hypertension-related heart disease, congestive heart failure, hypertensive nephropathy, and end stage renal disease1,2 Controlling blood pressure reduces cardiovascular morbidity and mortality. A 12 to 13 point reduction in blood pressure can reduce the number of heart attacks by 21%, strokes by 37% and all deaths from cardiovascular disease by 25% Estimated direct and indirect cost of hypertension for 2009 is $73.4 billion THE DATA

slide-3
SLIDE 3

Aetna tna’s A African A n America can n Hypertension S

  • n Stud

tudy

GOALS INITIATIVE RESULTS

Increase the rate of clinically acceptable blood pressure measurements among African American members Measure the impact of initiative on blood pressure and self care knowledge and behaviors of a Culturally Competent Disease Management Program (CCDMP) relative to a Light Support Program

(LSP) Two arm study evaluating CCDMP and LSP disease management program CCDMP components include:

  • culturally appropriate

mailings

  • outbound member

care calls

  • physician cultural

competency training

  • quarterly reporting to

physicians The CCDMP was effective in increasing the percentage of members with clinically acceptable blood pressure by 36% compared to the members in the LSP

slide-4
SLIDE 4

Hyp ypertension ion P Pilot

  • t

Program O m Ove vervi view

  • Th

e Commercial hypertension pilot program is based on two

different initiatives.

  • One focused on the Medicare population and the other

focused on the Commercial African American population, both showing improvements in clinically acceptable blood pressure control

  • The main goal is to improve blood pressure control to within

clinical practice guidelines through program outreach, educational support and monitoring

  • The program is expected to have a favorable impact on blood

pressure control, productivity and health care costs

slide-5
SLIDE 5

Hyp ypertension ion P Pilot

  • t

Program m – El Eleme ments ts

  • Member Identification

Member Outreach Member Health Education Biometric Monitoring Member Follow-up

slide-6
SLIDE 6

Meas easures res

  • f Su

Succes ess

  • Program enrollment rates

Improved compliance with BP monitoring Maintain and/or improve medication adherence for anti-hypertension medications Improvement in blood pressure control

slide-7
SLIDE 7

Le Lessons ns Le Learn arned – Mov Moving from

  • m

Resear arch t to Prac Practice

  • Value demonstration
  • Resource requirements
  • Cross functional integration
  • Speed to market / time to implementation
slide-8
SLIDE 8

Disclaimer

The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the Agency for Healthcare Research and Quality.